Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 12:03 pm Purchase | 13G | Omega Therapeutics Inc. OMGA | FMR LLC | 5,888,549 10.678% | 601,974 (+11.39%) | View |
| 2024-02-09 4:17 pm Purchase | 13G | Omega Therapeutics Inc. OMGA | HarbourVest Partners L.P. | 3,512,110 6.400% | 865,051 (+32.68%) | View |
| 2024-02-09 09:28 am Sale | 13G | Omega Therapeutics Inc. OMGA | FMR LLC | 5,286,575 9.587% | -271,003 (-4.88%) | View |
| 2023-03-10 09:30 am Purchase | 13G | Omega Therapeutics Inc. OMGA | FMR LLC | 5,557,578 10.102% | 958,135 (+20.83%) | View |
| 2023-02-27 5:02 pm Purchase | 13D | Omega Therapeutics Inc. OMGA | Flagship Ventures Fund V L.P. | 29,245,431 53.200% | 3,343,162 (+12.91%) | View |
| 2023-02-09 12:01 pm Purchase | 13G | Omega Therapeutics Inc. OMGA | FMR LLC | 4,599,443 9.572% | 169,762 (+3.83%) | View |
| 2022-02-14 07:01 am Purchase | 13G | Omega Therapeutics Inc. OMGA | HarbourVest Partners L.P. | 2,647,059 5.500% | 2,647,059 (New Position) | View |
| 2022-02-09 10:24 am Purchase | 13G | Omega Therapeutics Inc. OMGA | FMR LLC | 4,429,681 9.271% | 4,429,681 (New Position) | View |
| 2021-08-05 6:43 pm Purchase | 13D | Omega Therapeutics Inc. OMGA | Flagship Ventures Fund V L.P. | 25,902,269 55.400% | 25,902,269 (New Position) | View |